Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Cholecystectomy & appendectomy · Maine | Cholecystectomy & appendectomy · New York | |
|---|---|---|
| Surgeons, 2024 | 3 | 96 |
| Medicare fee-for-service cases | 578 | 5,762 |
| Growth since 2019 (Medicare FFS) | −9.6%/yr | −3.7%/yr |
| Forecast cases (Medicare FFS) | 630 in 2030 | 6,020 in 2030 |
| Forecast growth | +1.4%/yr to 2030 | +0.7%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 3.8 | 3.3 |
| Medicare Advantage share | 62% | 57% |
| Out of hospital | 0% (+0 pts since 2019) | 2% (−0 pts since 2019) |
| Cases per surgeon | 193 | 60 |
| Top 10 surgeons' share | 100% | 19% |
| Surgeons growing | 0 | 2 |
| New since the base year | 1 | 8 |
| Likely to stop billing it | 2 by 2026 | 45 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $191 | $2,795 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.